Hospital Smarts Contributors

Dr. Theodore Tyberg is a board certified internist and cardiologist. He graduated Alpha Omega Alpha (the Phi Beta Kappa of medical schools) from Rush University Medical University in Chicago. His internship and residency was completed at Cornell University Medical Center.  His cardiology training was done at Yale University Medical Center.

He has been on the staff at Weill Cornell Medical Center since 1980. During those years, he has been president of the attending staff, the staff representative to the General Faculty Council, secretary treasurer of the NY State chapter of the American College of Cardiology and treasure of the Center Alumni Council.

He is the cardiology consultant to the Rogosin Comprehensive Lipid Control Center and the scientific board of Kadmon pharmaceuticals.

Kenneth O. Rothaus, MD is a board-certified New York plastic surgeon and an honors graduate of both Yale College and the Harvard Medical School. Having excelled in both the classroom and clinical rotations as well as the research laboratory, Dr. Rothaus went on to train for his surgical internship and residency at the prestigious New York Presbyterian Columbia Medical Center. He followed that with his residency in plastic surgery at the New York Hospital-Cornell University Medical Center, to which he returned as an attending staff and faculty member after completing a microsurgical fellowship.

Dr. Rothaus values the wants and needs of his patients and strives to give them the best experience possible. With both a national and international practice, Dr. Rothaus has extensive experience in a number of plastic surgery treatments and techniques. As a distinguished surgeon, husband, and parent, Dr. Rothaus has profound appreciation for the apprehension a patient, spouse or parent may feel approaching a surgical procedure, and feels that trust and communication is of the upmost importance in developing a close doctor-patient relationship.

Dr. Rothaus has appeared on several television and radio programs

The book that Dr. Rothaus co-authored with Dr. Theodore Tyberg, Hospital Smarts, (and the basis for this website) provides invaluable information to the average patient in order to empower them, and is considered “recommended reading” by numerous hospitals and medical groups for anyone going to a hospital for care. As a father of three sons, as well as a distinguished surgeon, Dr. Rothaus holds himself to the highest standards and commitment to the individual patient and the doctor-patient relationship. He feels that knowledge will empower his patients and enable to make well-informed, confident decisions regarding the medical care they receive.

Dr. Kemeny is a medical oncologist with a special expertise in developing new chemotherapy regimens for colorectal cancer. During her 40 years at Memorial Sloan Kettering, she conducted some of the first studies using drugs such as irinotecan (Camptosar®) and oxaliplatin (Eloxatin®), which are now widely used in patients with colorectal cancer. She was also the lead investigator of a large, multi-institutional study that helped in the Food and Drug Administration’s approval of oxaliplatin for colorectal cancer treatment in the U.S.

In addition to her clinical and research responsibilities at Memorial Sloan Kettering, she is a professor of medicine at Weill Cornell Medical College. Dr. Kemeny is also active in oncology issues on a national level. In 1990, she served as a member of the Oncology Drug Advisory Committee, and has held various positions at the American Society of Clinical Oncology (ASCO). She was one of ASCO’s directors from 1990 to 1993; chairperson of the Membership Committee from 1986 to 1989; chairperson of the Special Awards Committee from 1991 to 1995; a member of the ASCO Grant Selection Committee from 2003 to 2004; and a member of the CEA Tumor Marker Panel. In addition, she was principal investigator of a national CALGB protocol evaluating regional liver therapy versus systemic therapy in patients whose disease had spread from the colon to the liver. The study demonstrated a significant increase in survival with regional therapy. Dr. Kemeny is also a scientific reviewer for many journals and on the editorial board of three journals.

Dr. Kara N. Goldman is an Assistant Professor of Obstetrics and Gynecology and Reproductive Endocrinology and Infertility at New York University Langone Medical Center. After graduating Cum Laude from Duke University, she received her medical degree from Loyola University Chicago, completed internship in Obstetrics and Gynecology at Washington University in St. Louis, residency in OB/GYN at Northwestern University, and fellowship in reproductive endocrinology and infertility at New York University. She is a board-certified Fellow of the American Congress of Obstetricians and Gynecologists and a member of the American Society for Reproductive Medicine.

Dr. Goldman is a passionate advocate for reproductive health in women, and in 2015 was awarded two prestigious research awards from the American Society for Reproductive Medicine and the Foundation for Women’s Wellness to study fertility preservation in women facing cancer treatment. She has received numerous clinical and teaching awards and has lectured nationally and internationally on a wide range of topics in reproductive health. Actively involved in medical research, she has published 17 peer-reviewed scientific manuscripts and a textbook chapter and is on the editorial board of the Journal of Assisted Reproduction & Genetics.

She specializes in all medical and surgical aspects of reproductive medicine.

Dr. Amy Tyberg is an Assistant Professor of Medicine at the Weill Cornell Medical College and Attending Physician at New York Presbyterian Hospital/Weill Cornell Medical Center. She is board certified in gastroenterology and internal medicine.

Dr. Tyberg received her undergraduate degree from Duke University, followed by her medical degree from New York Medical College. She completed internship and residency training at New York Presbyterian Hospital – Weill Cornell Medical Center.
Dr. Tyberg specializes in diseases of the pancreas and biliary tract including acute and chronic pancreatitis, management and drainage of pancreatic fluid collections, pancreatic cancer and cholangiocarcinoma. She focuses on therapeutic ERCP including biliary stenting, lithotripsy, radiofrequency ablation and PDT, as well as diagnostic and therapeutic EUS including FNA of pancreatic cysts and endoscopic-guided drainage of pancreatic fluid collections.

Dr. Tyberg is involved in many published and ongoing research projects, and is committed to continuing research towards finding new and innovative ways to help her patients in a minimally invasive fashion.

Alexander Mauskop, MD is the founder and director of the New York HeadacheCenter. He is a Professor of Clinical Neurology at SUNY, Downstate Medical Center.Dr. Mauskop has conducted and published original research on Botox, magnesium,herbal products, and drugs for the treatment of headaches. He serves as a reviewerfor medical journals, such as New England Journal of Medicine, Neurology, and Headache. His research led to the development of an over-the- counter headachemedication, Migralex.

Over 200 doctors from all over the world have visited the New York HeadacheCenter to receive advanced training from Dr. Mauskop. He has given lectures andgrand rounds at institutions such as Cornell, Harvard, Columbia, NYU andDartmouth Medical Schools, and Mayo and Cleveland Clinics.

Oxford University Press has published two editions of his textbook for doctors,Migraine and Headache. He has also written two books for the general public – TheHeadache Alternative: A Neurologist’s Guide to Drug-Free Relief and What YourDoctor May Not Tell You About Migraines.

Daniel M. Libby, MD, is Clinical Professor of Medicine, Pulmonary and Critical Care Medicine, Weill Medical College of Cornell University and Attending Physician, The New York Presbyterian Hospital. Dr. Libby has been in private practice for 30 years after spending seven years on the full time faculty at Cornell Medical College. He received the Andrew Mellon Teacher Scientist award and was elected to the Alpha Omega Alpha Medical Society at Baylor College of Medicine, Houston, Texas.

Dr. Libby has extensive teaching experience with medical students, interns, residents, and Pulmonary Fellows and has done clinical research in several areas of Pulmonary Medicine, having published over 80 articles in peer reviewed medical journals on topics such as pulmonary physiology, alveolar macrophages, and CT screening for lung cancer. His current clinical research interest in conjunction with the Department of Genetic Medicine is the development of genetic biomarkers of lung cancer taken from nasal brushings.

Dr. Libby has served in leadership positions on the Weill Cornell Medical College Board of Overseers, The Medical Board of the New York Presbyterian Hospital, the Committee of Review (Promotions), the Board of Directors of the Griffis Faculty Club and President of the Association of Practicing Physicians. Extra-curricular positions include President of the Board of the 333 East 68th Street Cooperative Corporation and President of the New York City Physicians Golfing Associations. Social memberships include The River Club of New York and the Lake Mohawk Golf Club, Sparta, New Jersey.